Selexipag
Selexipag (pronunciation: sə-LEK-si-pag) is a medication used for the treatment of pulmonary arterial hypertension (PAH). It is classified under the drug class of prostacyclin receptor agonists.
Etymology
The term "Selexipag" is a coined, proprietary, non-systematic name, and its etymology is not publicly disclosed.
Pharmacology
Selexipag works by relaxing and widening the blood vessels (arteries) in the lungs, which makes it easier for the heart to pump blood through the lungs. It is a selective prostacyclin IP receptor agonist that is hydrolyzed to its active metabolite in the liver.
Usage
Selexipag is used to treat pulmonary arterial hypertension (PAH) to improve exercise ability and delay clinical worsening. It is usually taken orally twice a day, with or without food.
Side Effects
Common side effects of Selexipag include headache, diarrhea, jaw pain, nausea, muscle pain, vomiting, and flushing. If any of these effects persist or worsen, patients are advised to tell their doctor or pharmacist promptly.
Related Terms
- Pulmonary arterial hypertension
- Prostacyclin receptor agonists
- Blood vessels
- Prostacyclin IP receptor
See Also
External links
- Medical encyclopedia article on Selexipag
- Wikipedia's article - Selexipag
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski